ARCH Venture Fund VII, L.P.

CIK 00014024397 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001402439

Recent Transactions

50 trades

Other
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-12-08+703,061→ 1,387,228 total
Other
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-12-08+1,176,593→ 2,321,566 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19+684,167→ 684,167 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19+1,144,973→ 1,144,973 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19+6,576,400→ 11,886,758 total
Purchase
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19$17.00/sh+1,500,000→ 3,624,143 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Series A-2 Preferred Stock
2023-09-19−6,895,021→ 0 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Series A-1 Preferred Stock
2023-09-19−684,167→ 0 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19+2,124,143→ 2,124,143 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Series A-1 Preferred Stock
2023-09-19−1,144,973→ 0 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Series A-2 Preferred Stock
2023-09-19−6,576,400→ 0 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Series B Preferred Stock
2023-09-19−2,124,143→ 0 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19+6,895,021→ 12,205,379 total
Conversion
908 Devices Inc.$MASS
Series C Preferred Stock
2020-12-22−669,977→ 0 total
Conversion
908 Devices Inc.$MASS
Series D Preferred Stock
2020-12-22−665,661→ 0 total
Conversion
908 Devices Inc.$MASS
Common Stock, par value $0.001
2020-12-22+5,425,045→ 5,425,045 total
Purchase
908 Devices Inc.$MASS
Common Stock, par value $0.001
2020-12-22$20.00/sh+300,000→ 5,725,045 total
Conversion
908 Devices Inc.$MASS
Series B Preferred Stock
2020-12-22−981,443→ 0 total
Conversion
908 Devices Inc.$MASS
Series E Preferred Stock
2020-12-22−180,578→ 0 total
Conversion
908 Devices Inc.$MASS
Series A Preferred Stock
2020-12-22−2,927,386→ 0 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-07-17$7.70/sh−34,521→ 4,242,051 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-07-16$7.81/sh−25,779→ 4,276,572 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-07-15$8.27/sh−2,700→ 4,302,051 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-14$8.15/sh−43,000→ 4,305,051 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-13$8.20/sh−2,820→ 4,348,051 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-13$7.89/sh−81,591→ 4,350,871 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-12$7.37/sh−40,092→ 4,432,462 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-11$6.49/sh−44,878→ 4,472,554 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-08$6.93/sh−84,496→ 4,517,432 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2019-03-07$6.87/sh−35,209→ 4,601,928 total
Conversion
Twist Bioscience Corp$TWST
Common Stock
2018-11-02+1,182,645→ 1,182,645 total
Conversion
Twist Bioscience Corp$TWST
Series B Preferred Stock
2018-11-02−718,275→ 0 total
Conversion
Twist Bioscience Corp$TWST
Series D Preferred Stock
2018-11-02−894,146→ 0 total
Purchase
Twist Bioscience Corp$TWST
Common Stock
2018-11-02$14.00/sh+60,000→ 954,146 total
Conversion
Twist Bioscience Corp$TWST
Series C Preferred Stock
2018-11-02−266,776→ 0 total
Conversion
Twist Bioscience Corp$TWST
Common Stock
2018-11-02+266,776→ 2,167,696 total
Purchase
Twist Bioscience Corp$TWST
Common Stock
2018-11-02$14.00/sh+15,000→ 2,407,422 total
Conversion
Twist Bioscience Corp$TWST
Series D Preferred Stock
2018-11-02−224,726→ 0 total
Conversion
Twist Bioscience Corp$TWST
Common Stock
2018-11-02+718,275→ 1,900,920 total
Conversion
Twist Bioscience Corp$TWST
Common Stock
2018-11-02+224,726→ 2,392,422 total
Conversion
Twist Bioscience Corp$TWST
Common Stock
2018-11-02+894,146→ 894,146 total
Conversion
Twist Bioscience Corp$TWST
Series A Preferred Stock
2018-11-02−1,182,645→ 0 total
Conversion
Unity Biotechnology, Inc.
Common Stock
2018-05-07+195,672→ 1,682,417 total
Conversion
Unity Biotechnology, Inc.
Series C Preferred Stock
2018-05-07−195,672→ 0 total
Conversion
Unity Biotechnology, Inc.
Common Stock
2018-05-07+2,030,625→ 2,070,172 total
Conversion
Unity Biotechnology, Inc.
Common Stock
2018-05-07+4,228,432→ 6,298,604 total
Conversion
Unity Biotechnology, Inc.
Common Stock
2018-05-07+2,067,160→ 8,365,764 total
Conversion
Unity Biotechnology, Inc.
Common Stock
2018-05-07+1,486,745→ 1,486,745 total
Conversion
Unity Biotechnology, Inc.
Series A-1 Preferred Stock
2018-05-07−2,030,625→ 0 total
Conversion
Unity Biotechnology, Inc.
Series A-2 Preferred Stock
2018-05-07−4,228,432→ 0 total

Companies

Recent Filings

Address

8755 W HIGGINS SUITE 1025

CHICAGO, IL, 60631

View on SEC.gov